According to Inkwood
Research, the Global Smart Inhalers Market is projected to register a CAGR of
31.66% in terms of revenue during the forecast period, 2019-2028.
“Browse
31 Market Data Tables and 41 Figures spread over 163 Pages, along with an
in-depth TOC on the Global Smart Inhalers Market Forecast
2019-2028.”
REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/smart-inhalers-market/#request-free-sample
Inhalers are devices that are
used to deliver medication through inhalation. The drugs used in inhalers are
glucocorticoids, insulin, anti-cholinergic, and beta-agonists. They are used
for the treatment and prevention of respiratory diseases like COPD and asthma.
Smart inhalers entail sensors attached as a clip on to the inhalers that
monitor the right intake of dose and technique for inhaling the medication. The
data thus acquired is shared with the healthcare professionals.
The data sharing happens
through Bluetooth technology and platforms like Hailie. Hailie systems are a
type of sensors attached to the inhaler for tracking health and adherence rates.
Smart inhalers are said to have increased the adherence rate in patients
suffering from asthma and COPD.
Rising Chronic Respiratory Diseases Propels the
Global Market
The diseases that affect the
airways and other parts of the lungs are known as chronic respiratory diseases.
As per a report in 2018, these diseases affect more than 1 billion people
across the globe. The respiratory symptoms are both the major indicators and
causes of consultation with physicians in primary health care centers. Asthma,
allergic rhinitis, sleep apnea, tuberculosis, chronic obstructive pulmonary
disease (COPD), are among the preventable chronic respiratory disorders. Among
these, asthma is one of the most prominent diseases affecting children, the elderly
population, and adults alike. The prevalence of asthma, of severe nature, is
noticed more in the Middle East & Africa and Latin America, in comparison
to Europe, Asia Pacific, and North America.
Tobacco smoking is cited as
the root cause of respiratory diseases, especially chronic obstructive
pulmonary disease (COPD). The other reason that trails behind is the rising
environmental pollution in industrial lands and metropolitan cities. While
ample initiatives are being implemented to tackle COPD, the growing geriatric
population is deemed to be a severe challenge in the years to come. These
diseases are responsible for the rising hospitalization rates in low- and
middle-income countries.
Smart Nebulizer is set to become the Most
Prominent Product with highest CAGR
Smart Nebulizers are machines
that turn liquid asthma medication into gas or mist, which is inhaled by the
patient. They are either electric- or battery-powered. The mist is inhaled
through a facemask or mouthpiece. They come in varied shapes and sizes, and are
heavy and noisy. Hence, they required to be plugged in during the process. It
is ideal for patients who require routine treatment for asthma and COPD at
home. Also, it is one of the conventional methods utilized for administering
medical aerosol.
The smart nebulizer is
further categorized into pneumatic nebulizer, ultrasonic nebulizer, and mesh
nebulizer. In terms of portability, it is segregated into tabletop nebulizer
and portable nebulizer. The pneumatic nebulizer is the most commonly used
device, and is in huge demand and preference as a result of its improved
suitability toward all types of medicines. The rising demand is also attributed
to effective drug delivery and ease of handling.
Asia Pacific is projected to lead from the
front with highest CAGR by 2028
Major countries that propel
the growth of the Asia Pacific market are Japan, India, China, South Korea,
Vietnam, Thailand, and Australia & New Zealand. The region of Asia Pacific
is deemed to be a potential market for smart inhalers. This is owed to the
rapid development of healthcare infrastructure, increasing disposable income,
and the rising awareness with regard to the benefits of smart inhalers. China
and India are witnessing fast-paced economic developments, along with housing a
large population, all of which will provide ample growth opportunities for the
market under study.
The market is projected to
encompass several opportunities for new companies. The market also has the
presence of many small and large companies, and is thus fragmented. The
competition among the players is evaluated to be strong. Some of the
well-established firms in the market include, Adherium Limited, Boehringer
Ingelheim GmbH, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceutical
Industries Limited, etc.
About Inkwood Research
Inkwood Research specializes in
syndicated & customized research reports and consulting services. Market
intelligence studies with relevant fact-based research are customized across
industry verticals such as technology, automotive, chemicals, materials,
healthcare, and energy, with an objective comprehension that acknowledges the
business environments. Our geographical analysis comprises of North & South
America, CEE, CIS, Middle East, Europe, Asia, and Africa.
Contact Us
+1 857-302-4704
Related Reports:
Comments
Post a Comment